Jyong Biotech Ltd.

Contributing Author

Recent Articles by Jyong Biotech Ltd.

Dec-04	Jyong Biotech Expands Regional Partnerships, Signs MOU with a Vietnam Pharmaceutical Distributor for MCS-2 Market Entry MENS GlobeNewswire
Nov-24	Jyong Biotech Ltd. Signs Non-Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In-Licensing of Plant-Derived MCS Drugs MENS GlobeNewswire
Nov-20	Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes MENS GlobeNewswire
Sep-29	Jyong Biotech Wins Innovation Gold Award in Pharmaceutical Category at 2025 Taipei Biotech Awards MENS GlobeNewswire
Sep-18	Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei MENS GlobeNewswire
Sep-16	Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS-8 for Prostate Cancer Prevention MENS GlobeNewswire
Aug-22	Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP) MENS GlobeNewswire
Jul-22	Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention MENS GlobeNewswire
Jun-18	Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering MENS GlobeNewswire